AC Immune SA (ACIU)
NASDAQ: ACIU · Real-Time Price · USD
3.030
+0.190 (6.69%)
At close: Apr 28, 2026, 4:00 PM EDT
3.030
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:00 PM EDT
AC Immune Employees
As of December 31, 2025, AC Immune had 122 total employees, including 90 full-time and 32 part-time employees. The number of employees decreased by 50 or -29.07% compared to the previous year.
Employees
122
Change (1Y)
-50
Growth (1Y)
-29.07%
Revenue / Employee
$36,934
Profits / Employee
-$728,210
Market Cap
300.58M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Cellectis | 229 |
| Abeona Therapeutics | 226 |
| Cabaletta Bio | 156 |
| LENZ Therapeutics | 152 |
| Foghorn Therapeutics | 106 |
| Zentalis Pharmaceuticals | 106 |
| Editas Medicine | 87 |
| Inhibikase Therapeutics | 35 |
ACIU News
- 21 days ago - AC Immune Announces Amendment to Morphomer ® Tau License and Collaboration Agreement with Lilly - GlobeNewsWire
- 6 weeks ago - AC Immune Reports Full Year 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 4 months ago - AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga
- 4 months ago - AC Immune Transcript: Study Update - Transcripts
- 4 months ago - AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson's Disease - GlobeNewsWire
- 5 months ago - AC Immune Transcript: Jefferies London Healthcare Conference 2025 - Transcripts
- 6 months ago - AC Immune Reports Third Quarter 2025 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 6 months ago - First Characterization of a TDP-43 PET Tracer Published in Nature Communications Showing Potential of AC Immune's ACI-19626 in Precision Medicine - GlobeNewsWire